Cargando…

S49. Clinical activity and development of biomarkers for an engineered anti PDL1 antibody MPDL3280A

Detalles Bibliográficos
Autor principal:	Cha, E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072172/ http://dx.doi.org/10.1186/2051-1426-2-S2-I21

Ejemplares similares

Circulating and tumor-based biomarkers predict clinical activity in cancer patients treated with the engineered anti-PD-L1 antibody MPDL3280A
por: Kowanetz, Marcin, et al.
Publicado: (2014)

P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A)
por: Kowanetz, M, et al.
Publicado: (2014)

Myeloid cell biology and inhibition of anti-tumor immune responses by MPDL3280A in urothelial bladder cancer
por: Xiao, Yuanyuan, et al.
Publicado: (2014)

Intratumoral characteristics of tumor and immune cells at baseline and on-treatment correlated with clinical responses to MPDL3280A, an engineered antibody against PD-L1
por: Kohrt, Holbrook, et al.
Publicado: (2013)

Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC)
por: Powles, Thomas, et al.
Publicado: (2015)

S48. Biomarker development for ipilimumab and prostate GVAX treatment
por: de Gruijl, T, et al.
Publicado: (2014)

Using biomarkers prospectively in adaptive clinical trials
por: Berry, Donald A
Publicado: (2011)

INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022)

Discussion session: biomarker trials
Publicado: (2015)

S6. Proffered paper: Anti-tumour immunomodulatory activity of heat shock protein Hsp70 in therapy of malignant brain tumours: preclinical and clinical data
por: Shevtsov, M, et al.
Publicado: (2014)

New anti HCV drugs in the pipeline
por: Bourlière, Marc
Publicado: (2010)

Universal access to anti-HIV therapy
por: Souteyrand, Yves
Publicado: (2012)

New tools to diagnose and follow FAC patients: biomarkers
por: Merlini, Giampaolo
Publicado: (2015)

Is lack of habituation a biomarker of migraine? A critical perspective
por: Brighina, Filippo, et al.
Publicado: (2015)

Anti-latency agents to purge HIV reservoirs
por: Moreno, Santiago
Publicado: (2012)

Resistance to new antiretrovirals (ETV, anti-integrases, entry inhibitors)
por: Ceccherini-Silberstein, Francesca
Publicado: (2010)

Controversies about the role of the deficit of habituation of evoked potentials in migraine: a disease biomarker? PROS
por: Ambrosini, Anna
Publicado: (2015)

S38. Many reasons for combining immunotherapy with chemotherapy to enhance anti tumour response
por: Dalgleish, A, et al.
Publicado: (2014)

S35. Investigating the ICOS/ICOSL pathway as a target for combination therapy with anti-CTLA-4
por: Sharma, P
Publicado: (2014)

Regulation of shoot-system development in Populus
por: Brunner, Amy, et al.
Publicado: (2011)

Development of ICD 11: changes and challenges
por: Zafar, A, et al.
Publicado: (2012)

Research and development for the malaria elimination/eradication roadmap
por: Tanner, Marcel, et al.
Publicado: (2010)

Analgesic drug development: time to break the mould
por: Woolf, Clifford
Publicado: (2013)

ASEAN Health in the post-2015 development agenda
por: Prakongsai, Phusit
Publicado: (2014)

Clinical use of pharmacogenomics
por: Telenti, Amalio
Publicado: (2012)

Identification of genes and alleles influencing wood development in Eucalyptus
por: Southerton, Simon, et al.
Publicado: (2011)

Clinical impact of food processing
por: Baumert, Joseph
Publicado: (2011)

Immunological and clinical effects of probiotics
por: Eigenmann, Philippe
Publicado: (2011)

The clinical picture and outcome in adults
por: Elewaut, Dirk
Publicado: (2014)

Spondyloarthritis - the clinical picture in children
por: Vargas, Ruben Burgos
Publicado: (2014)

Seven myths of randomisation in clinical trials
por: Senn, Stephen
Publicado: (2011)

Clinical utility of thresholds versus CRD
por: Bindslev-Jensen, Carsten
Publicado: (2011)

INSP-05. Development of fast cortical rhythms in health and mental disease
por: Hanganu-Opatz, Ileana
Publicado: (2022)

Development of an attenuated sporozoite vaccine to prevent and eliminate Plasmodium falciparum malaria
por: Billingsley, Peter F
Publicado: (2010)

Developing sub-acute, non-acute and special groups in the universal grouper
por: Aljunid, Syed Mohamed
Publicado: (2012)

Developing sub-acute and non-acute Casemix classification: the Thailand experience
por: Pannarunothai, Supasit
Publicado: (2012)

PReS13-SPK-1107: Development of an academic pediatric rheumatology program
por: Laxer, R
Publicado: (2013)

PReS13-SPK-1137: New developments in our care & understanding of JIA
por: Beresford, MW
Publicado: (2013)

PReS13-SPK-1478: New developments in our care & understanding of JIA
por: Wedderburn, L
Publicado: (2013)

The heel fat pad: mechanical properties and clinical applications
por: Wearing, Scott C, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_lhgibv6csgvuat6egcq0nijhev